Citations

Clear

11 citation(s) found for "Siegel, Leslie".

Special populations require special research approaches
Crowley, Patrick D , Siegel, Leslie , Dickinson, Drew T , Lahr, Brian , Whalen, Francis X. , Challener, Douglas

Mayo Clinic

Clinical Infectious Diseases | October 18, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/cid/ciag675 | PMID 42956821 Get It

The hospice setting is unique for patient care and requires different techniques to study than other populations.
Relationship between Antibiotic Prescription and Survival in Hospice
Crowley, Patrick , Siegel, Leslie R. , Dickinson, Drew T. , Lahr, Brian D. , Whalen, Francis X. , Challener, Douglas W. , Crowley, Patrick D , Siegel, Leslie

Mayo Clinic

Clinical Infectious Diseases | September 10, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/cid/ciag561 | PMID 42725640 Get It

Abstract Background At hospice enrollment, patients are asked preferences regarding antibiotic use. Limited evidence on how these medications impact survival makes it difficult for clinicians to offer clear guidance. To support decision-making and antimicrobial stewardship, we assessed the association between antibiotic use and survival in outpatient hospice patients. Methods The association between antibiotic use and survival was evaluated using a time-dependent Cox proportional hazards model, adjusted for age, sex, Charlson Comorbidity Index, and hospice-qualifying conditions (HQCs). The cohort included patients enrolled in a large health system’s outpatient hospice program between June 20, 2017, and January 1, 2023. Results Among 6169 patients with an HQC, 1233 received at least one antimicrobial prescription during the study period. The median time from hospice enrollment to first prescription was 16 days (IQR 3-83). Antimicrobial prescribing patterns varied by HQC category. In time-dependent Cox models, antibiotic use was associated with increased hazard of death (aHR 1.47; 95% confidence interval [CI], 1.37–1.57).Stratified analyses showed the strongest association with increased mortality in patients with cancer HQCs (aHR 1.67; 95% CI, 1.50–1.87) and a survival benefit in those with infectious HQCs (aHR 0.60; 95% CI, 0.40–0.89). Discussion Physicians, patients, and families often overestimate the benefits of antibiotics near the end of life. The observed increase in mortality shortly after antibiotic initiation suggests that symptoms prompting antibiotic use may reflect the dying process rather than treatable infection. Knowledge of the limited role of antibiotics in prolonging life in hospice settings may improve decision-making and enhance the quality of end-of-life care.
Methylene Blue Mouthwash for Oral Mucositis Pain in Cancer: An Open-Label, Non-Randomized Study
Karow, Jordan, Mackey, Regina M. , Olson, Emily, Wiste, Rachel, Siegel, Leslie R. , Strand, Jacob, Siegel, Leslie , Karow, Jordan C., Olson, Emily M. , Schroeder, Darrell R. , Lapid, Maria I.

Mayo Clinic

Journal of Pain & Palliative Care Pharmacotherapy | April 11, 2026 | Volume: 40 | Issue: 2 | Pages: 230-236

10.1080/15360288.2026.2655779 | PMID 41964386 Get It

Cardiovascular Risks of Nonsteroidal Anti-Inflammatory Drugs
Elliott, A. Bowes, Juresic, Sanny , Siegel, Leslie R. , Smith, Nathan T. , Siegel, Leslie, Elliott, Abigail

Mayo Clinic

The Clinical Journal of Pain | November 13, 2025 | Volume: 42 | Issue: 2 | Pages: No page available

10.1097/ajp.0000000000001341 | PMID 41230625 Get It

Objectives: The primary objective of this article was to examine literature from the last 10 years surrounding cardiovascular risks associated with NSAID use. Methods: A systematic search was developed to include randomized control trials and systematic review meta-analyses that focused on the cardiovascular effects associated with NSAID use. Results: The search and screen identified 10 articles published in the last 10 years to be included in the review. Discussion: The most common cardiovascular risks studied in the included literature were hemodynamic effects and myocardial infarction. The evidence in the included studies suggests that concerns of adverse hemodynamic effects may be overstated with short-term NSAID use. Myocardial infarction was shown to be a very serious, but rare, side effect associated with NSAID use. Practitioners should weigh this risk when using NSAIDs in patients with an increased risk of MI at baseline. Other included studies described risks of Kounis syndrome, QTc prolongation, and potential reversal of right ventricular dysfunction in patients using NSAIDs.
Improving Skeletal Muscle Relaxant Stewardship
Smith, Nathan T. , Bye, Kyo , Pitterle, Alyssa, Siegel, Leslie R. , Ming, Emily, Lewis, Ryan, Cunningham, Julie L. , Bye, Katelyn, Lewis, Ryan

Mayo Clinic

Journal of Pain & Palliative Care Pharmacotherapy | September 8, 2025 | Volume: 39 | Issue: 3 | Pages: 445-445

10.1080/15360288.2025.2533676 Get It

Survival Variations Based on Hospice Qualifying Condition: A Retrospective Review
Crowley, Patrick , Siegel, Leslie R. , Whalen, Francis X. , Crowley, Patrick D

Mayo Clinic

American Journal of Hospice and Palliative Medicine® | August 26, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/10499091251374172 | PMID 40857749 Get It

Background Patients are enrolled into hospice for a variety of conditions. There are few recent data on the differences of survival duration after hospice enrollment, particularly regarding age, sex, and reason for hospice admission. Methods Using previously obtained data, we calculated age at enrollment, reported sex, and classified patients into nine classes of hospice-qualifying conditions (HQC). We then applied Wilcoxon rank-sum analysis comparing median survival and the percent of patients surviving at least 6 months. Findings 53.38% of patients were female. The median age was 83.03 years. The median survival duration overall was 17.36 days (Inter-quartile range 5.35-62.08). Median survival was lowest for “Infectious” HQC (4.69d) and highest for “Other” (28.53d). Women survived longer than men (19.34 vs 15.37 days). Those older than median survived longer (20.51 days vs 15.03). Overall, 9.47% of enrollees survived at least 6 months. This was more common for women (10.99%), those older than 83 (12.44%), and those enrolled for dementia (16.46%). Discussion Relevant information of what can be expected after hospice enrollment is crucial for families and patients. These differences also indicate potential bias in assessment of hospice applicability, enrolling women, older patients, and patients with specific diagnoses earlier in their disease course.
Post-Operative Bleed Risks Associated with Perioperative Nonsteroidal Anti-Inflammatory Drugs: A Narrative Review
Seitz, Laura Louise , Juresic, Sanny , Siegel, Leslie R. , Smith, Nathan T. , Seitz, Laura L , Siegel, Leslie

Mayo Clinic

Journal of Pain & Palliative Care Pharmacotherapy | August 19, 2025 | Volume: 39 | Issue: 4 | Pages: 518-524

10.1080/15360288.2025.2547839 | PMID 40828145 Get It

Common Antimicrobial Treatment Considerations for Patients Receiving Comfort-Focused Care: What the Hospice Provider Should Know
Crowley, Patrick , Siegel, Leslie R. , Crowley, Patrick D , Dickinson, Drew T.

Mayo Clinic

Journal of Palliative Medicine | May 8, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1089/jpm.2025.0040 | PMID 40337803 Get It

Determinants of Antibiotic Prescription in Outpatient Hospice: A Regional Observational Study
Crowley, Patrick , Whalen, Francis X. , Siegel, Leslie R. , Crowley, Patrick D , Challener, Douglas , Challener, Douglas W.

Mayo Clinic

American Journal of Hospice and Palliative Medicine® | February 3, 2025 | Volume: 43 | Issue: 2 | Pages: 172-178

10.1177/10499091251317662 | PMID 39895069 Get It

Background Patients enrolling in hospice care are asked their preferences for antibiotic treatment. There is little information regarding which patients are more likely to receive antibiotics. To better inform discussions, we sought to characterize the use of antibiotics in the outpatient hospice setting. Methods We performed a retrospective review of patients enrolled in outpatient hospice within the Mayo Clinic Health System from 1/1/2017 through 1/1/2023. We calculated what percent of patients received antibiotics based on Hospice Qualifying Condition (HQC), age at enrollment, sex, survival time, and Charlson Comorbidity Index and calculated adjusted odds ratios (aOR). We documented which antibiotics were prescribed based on HQC. Results Of 6452 patients identified, 1259 (19.5%) received antibiotic prescriptions. Cephalosporins were the most common class of antibiotics prescribed (22.8% of antibiotics prescribed), followed by fluoroquinolones (20.3%) and penicillin derivatives (14.9%). Patients with Pulmonary HQCs were most likely to receive antibiotics (28.6% aOR 1.85 [1.51-2.25]), those with neurologic HQCs were least likely (14.9% aOR 0.66 [0.53-0.83]). There was no difference of age for those receiving antibiotics (80.7 yr) vs those not receiving (80.3 yr [ P = 0.25]), or for sex (male vs female aOR 1.10 [0.96-1.26). 4.6% of those surviving <7d received antibiotics (aOR .22 [0.17-0.29]), compared to 47.7% of those surviving >6mo (aOR 4.46 [3.50-5.69]). Discussion 19.5% of patients will receive antibiotics during their hospice course, with more frequent prescriptions in those surviving longer periods and those enrolled for pulmonary conditions. It is important to clarify patient preferences regarding antimicrobial utilization at the time of hospice enrollment.
P-1657. Antibiotics in hospice and the patients who receive them
Whelan, Francis, Siegel, Leslie R. , Crowley, Patrick, Whelan, Francis, Challener, Douglas W.

Mayo Clinic

Open Forum Infectious Diseases | January 29, 2025 | Volume: 12 | Issue: Supplement_1 | Pages: No page available

10.1093/ofid/ofae631.1823 Get It

Abstract Background At the time of hospice enrollment, patients are asked whether they would potentially want antibiotics. This is little information regarding which patients are more likely to receive these antibiotics or the impact on comfort or longevity. To help guide discussions with patients and families and target future stewardship interventions, we sought to characterize the use of antibiotics in the outpatient hospice setting. Methods We performed a retrospective review of patients enrolled in hospice with the Mayo Clinic Health System -Midwest from 1/1/2017 through 1/1/2023. For those with documented Hospice Qualifying Condition (HQC), we assessed age at enrollment, gender, survival time (ST), and Charleston Comorbidity Index (CCI). We documented which antibiotics were prescribed and compared the rate of prescription based on the above characteristics. Results We identified 6452 patients with identifiable HQC. Of these, 1281 patients (19.8%) received 4173 antibiotic prescriptions. After removing refilled prescriptions, there were 2037 new prescriptions. Cephalosporins were the most common class of antibiotics prescribed (24.4% of antibiotics prescribed), followed by fluoroquinolones (19.9%), penicillin derivatives (14.4%), and trimethoprim (10.4%) (fig 1). Pulmonary (28.6%) and GI (31.9%) HQCs were most likely to receive antibiotics, neurologic was least likely (fig 2). There was no difference of age for those receiving antibiotics (80.6 yr) vs those not receiving (80.3 yr [p=0.53]), or for gender (male vs female OR 0.97 [0.86-1.10). CCI was higher in those patients who received antibiotics (4.3) than those not receiving (3.93, p&lt; 0.001). Patients were more likely to receive antibiotics the longer they survived on hospice (4.7% surviving &lt; 7d, 47.7% surviving &gt;6mo – fig 3). Conclusion Antibiotics are an important pharmaceutical tool in the hospice setting. Nearly 20% of patients in hospice will receive antibiotics during their hospice course, with higher chance in those surviving longer periods and those enrolled for GI or pulmonary reasons. Discussions of antibiotic are crucial for these groups, and antimicrobial steward efforts should consider focusing on these patients. Disclosures All Authors: No reported disclosures